SCHEMBL5299701

SCHEMBL5299701

COc1cccc([C@@H]2C(=O)NC(=O)[C@H]2c2cn3c4c(cccc24)CCC3)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPA1 O60313 1/20 0.61
EIF5B O60841 1/20 0.61
MET P08581 1/20 0.61
HMOX2 P30519 1/20 0.61
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
KMT2A Q03164 1/20 0.42
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
GID4 Q8IVV7 1/20 0.41
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
ALOX5 P09917 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
MTNR1A P48039 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395846 1.00 OPA1 (0.61) OPA1EIF5BMETHMOX2MEN1
SCHEMBL1395775 0.90 OPA1 (0.63) OPA1EIF5BMETHMOX2MEN1
SCHEMBL15872111 0.90 OPA1 (0.63) OPA1EIF5BMETHMOX2MEN1
SCHEMBL1395820 0.87 OPA1 (0.60) OPA1EIF5BMETHMOX2MEN1
SCHEMBL2875549 0.86 OPA1 (0.48) OPA1EIF5BMETHMOX2MEN1
SCHEMBL13248816 0.86 OPA1 (0.48) OPA1EIF5BMETHMOX2MEN1
SCHEMBL1395828 0.85 OPA1 (0.73) OPA1EIF5BMETHMOX2ALDH1A1
SCHEMBL3773941 0.85 OPA1 (0.64) OPA1EIF5BMETHMOX2KMT2A
SCHEMBL1395781 0.85 OPA1 (0.64) OPA1EIF5BMETHMOX2ALDH1A1
SCHEMBL1395825 0.85 OPA1 (0.64) OPA1EIF5BMETHMOX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846406-A1 MALEIMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER ArQule, Inc. (US) 2007-10-24 EP disclosed
WO-2006086484-A1 MELEIMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER ARQULE, INC. (US) 2006-08-17 WO disclosed